IDORSIA

idorsia-logo

The purpose of Idorsia is to discover, develop and commercialize innovative medicines to help more patients. We have more ideas, we see more opportunities and we want to transform the horizon of therapeutic options. In order to achieve this, we will develop Idorsia into a leading biopharmaceutical company, with a strong scientific core. Headquartered in Switzerland โ€“ a biotech-hub of Europe โ€“ Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development and commercialization of innovative small molecules, with the aim of transforming the horizon of therapeutic options.

#SimilarOrganizations #People #Financial #More

IDORSIA

Social Links:

Industry:
Biotechnology Health Care

Founded:
2017-06-01

Status:
Active

Contact:
41 58 844 00 00

Email Addresses:
[email protected]

Total Funding:
1.44 B USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Font Awesome Apache


Similar Organizations

aeovian-pharmaceuticals-logo

Aeovian Pharmaceuticals

Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.

cequr-logo

CeQur

CeQur develops and commercializes insulin delivery systems, giving people with type 2 diabetes freedom from multiple daily injections.

swords-labs-logo

Swords Labs

Bristol-Myers Squibb is a biopharma company that works to discover, and deliver innovative medicines that help patients fight disease.

transgenex-nanobiotech-logo

TransGenex Nanobiotech

TransGenex Nanobiotech is to discover, develop and commercialize nano-scale technologies for novel, cost-effective diagnostic.

Current Employees Featured

mike-ufer_image

Mike Ufer
Mike Ufer Senior Director Clinical Pharmacology @ Idorsia
Senior Director Clinical Pharmacology
2017-06-01

andrรฉ-c-muller_image

Andrรฉ C Muller
Andrรฉ C Muller EVP, Chief Financial Officer @ Idorsia
EVP, Chief Financial Officer
2017-06-01

martine-clozel_image

Martine Clozel
Martine Clozel Executive Vice President, Chief Scientific Officer @ Idorsia
Executive Vice President, Chief Scientific Officer
2017-06-16

jon-fuller_image

Jon Fuller
Jon Fuller Scientific Software Developer @ Idorsia
Scientific Software Developer
2019-11-01

jean-paul-clozel_image

Jean-Paul Clozel
Jean-Paul Clozel CEO @ Idorsia
CEO
2017-06-16

Founder


jean-paul-clozel_image

Jean-Paul Clozel

martine-clozel_image

Martine Clozel

Stock Details


Company's stock symbol is SIX:IDIA

Acquisitions List

Date Company Article Price
2020-07-23 Vaxxilon Vaxxilon acquired by Idorsia N/A

Investors List

carb-x_image

CARB-X

CARB-X investment in Grant - Idorsia

Investments List

Date Company Article Money raised
2021-09-20 Santhera Pharmaceuticals Idorsia investment in Post-IPO Equity - Santhera Pharmaceuticals 20 M CHF

More informations about "Idorsia" on Search Engine